Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SILO
SILO logo

SILO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Silo Pharma Inc (SILO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
6.120
1 Day change
5.34%
52 Week Range
15.150
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Silo Pharma Inc (SILO) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has regained Nasdaq compliance and is focused on promising biopharmaceutical developments, the lack of significant trading trends, neutral technical indicators, absence of strong proprietary trading signals, and limited financial data suggest that waiting for more clarity or stronger signals would be prudent.

Technical Analysis

The MACD is slightly positive but contracting, RSI is neutral at 48.049, and moving averages are converging, indicating no clear trend. Key support is at 5.82, and resistance is at 6.659. The stock's short-term price trend suggests limited upside potential with a 60% chance of a 1.21% increase in the next week but a potential decline of -1.98% in the next month.

Positive Catalysts

  • Silo Pharma has regained Nasdaq compliance, enhancing investor confidence. The company is advancing clinical trials for PTSD and developing its AI platform, QwikAgents. Collaborations with leading universities and laboratories strengthen its research capabilities.

Neutral/Negative Catalysts

  • No significant trading trends from hedge funds or insiders. Technical indicators and price trends do not suggest strong upward momentum. Limited financial data and valuation metrics are available for deeper analysis.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes are available.

Wall Street analysts forecast SILO stock price to rise
Analyst Rating
0
Wall Street analysts forecast SILO stock price to rise
Buy
Hold
Sell
0
Current: 5.810
sliders
Low
0
Averages
0
High
0
0
Current: 5.810
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch